Literature DB >> 1660204

Newcastle disease virus (NDV) vaccine based on immunization with avian cells expressing the NDV hemagglutinin-neuraminidase glycoprotein.

F L Cosset1, J F Bouquet, A Drynda, Y Chebloune, A Rey-Senelonge, G Kohen, V M Nigon, P Desmettre, G Verdier.   

Abstract

Newcastle disease virus (NDV) is a paramyxovirus that bears two envelope glycoproteins at the virion surface. These proteins, fusion and hemagglutinin-neuraminidase (HN), are involved in the immune response against NDV infection. Recombinant cells constitutively expressing at their surface the HN protein from the velogenic Texas strain were generated by introducing the HN gene with a helper-free AEV-based vector. These recombinant cells were used to immunize chickens by various protocols, and birds were subsequently challenged with a lethal NDV injection. Both NDV protection and serologic response were observed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1660204     DOI: 10.1016/0042-6822(91)90560-x

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Packaging cells for avian leukosis virus-based vectors with various host ranges.

Authors:  F L Cosset; C Ronfort; R M Molina; F Flamant; A Drynda; M Benchaibi; S Valsesia; V M Nigon; G Verdier
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

2.  Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes.

Authors:  Masoumeh Firouzamandi; Hassan Moeini; Davood Hosseini; Mohd Hair Bejo; Abdul Rahman Omar; Parvaneh Mehrbod; Aini Ideris
Journal:  J Vet Sci       Date:  2016-03-22       Impact factor: 1.672

Review 3.  Vectors derived from avian leukosis and sarcoma viruses.

Authors:  F Flamant; F L Cosset; J Samarut
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

4.  Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens.

Authors:  Sachin Kumar; Baibaswata Nayak; Peter L Collins; Siba K Samal
Journal:  J Virol       Date:  2011-04-27       Impact factor: 5.103

5.  Preparation and diagnostic utility of a hemagglutination inhibition test antigen derived from the baculovirus-expressed hemagglutinin-neuraminidase protein gene of Newcastle disease virus.

Authors:  Kang-Seuk Choi; Soo-Jeong Kye; Woo-Jin Jeon; Mi-Ja Park; Saeromi Kim; Hee-Jung Seul; Jun-Hun Kwon
Journal:  J Vet Sci       Date:  2013-06-28       Impact factor: 1.672

6.  Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.

Authors:  Shin-Hee Kim; Nanchaya Wanasen; Anandan Paldurai; Sa Xiao; Peter L Collins; Siba K Samal
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

Review 7.  Molecular characterization of hemagglutinin-neuraminidase fragment gene of Newcastle disease virus isolated from periodically-vaccinated farms.

Authors:  Lucia S Triosanti; Michael Haryadi Wibowo; Rini Widayanti
Journal:  Vet World       Date:  2018-05-20

8.  Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge.

Authors:  Ke Ding; Ke Shang; Zu-Hua Yu; Chuan Yu; Yan-Yan Jia; Lei He; Cheng-Shui Liao; Jing Li; Chun-Jie Zhang; Yin-Ju Li; Ting-Cai Wu; Xiang-Chao Cheng
Journal:  J Vet Sci       Date:  2018-03-31       Impact factor: 1.672

Review 9.  Development of Plant-Based Vaccines for Prevention of Avian Influenza and Newcastle Disease in Poultry.

Authors:  Ika Nurzijah; Ola A Elbohy; Kostya Kanyuka; Janet M Daly; Stephen Dunham
Journal:  Vaccines (Basel)       Date:  2022-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.